Related Experiment Videos
Interleukin-4 downregulates interleukin-6 production in human peripheral blood mononuclear cells
J D Lee1, S G Swisher, E H Minehart
1Department of Surgery, UCLA School of Medicine 90024.
Abstract:
We report that recombinant human interleukin-4 (IL-4) downregulates interleukin-6 (IL-6) production by human peripheral blood mononuclear cells (PBMC). PBMC were preincubated for up to 24 hr in the presence of IL-4 (100 U/ml) and then activated with lipopolysaccharide B Escherichia coli 026:B6 (LPS, 10 micrograms/ml), recombinant human tumor necrosis factor-alpha (TNF-alpha, 200 U/ml), or Concanavalin A (Con A, 10 micrograms/ml). Although all these signals induced IL-6 production, IL-4-treated cells produced significantly reduced levels of IL-6 protein. This effect was dose and time dependent. We conclude that IL-4 is a potent downregulatory modulator of IL-6 expression in human PBMC.
Insights
Recombinant human interleukin-4 (IL-4) significantly reduces interleukin-6 (IL-6) production in human peripheral blood mononuclear cells (PBMC). This immune modulation effect was observed across various activation signals and demonstrated dose and time dependency.
Area of Science:
- Immunology
- Cell Biology
Background:
- Interleukin-6 (IL-6) is a key pro-inflammatory cytokine.
- Understanding the regulation of IL-6 production is crucial for immune response modulation.
Purpose of the Study:
- To investigate the effect of recombinant human interleukin-4 (IL-4) on interleukin-6 (IL-6) production in human peripheral blood mononuclear cells (PBMC).
Main Methods:
- Human PBMC were preincubated with IL-4.
- Cells were subsequently activated using lipopolysaccharide (LPS), tumor necrosis factor-alpha (TNF-alpha), or Concanavalin A (Con A).
- IL-6 protein levels were measured.
Main Results:
- IL-4 preincubation significantly downregulated IL-6 protein production induced by LPS, TNF-alpha, and Con A.
- The observed downregulation of IL-6 was dependent on both the dose of IL-4 and the duration of preincubation.
- IL-4 acts as a potent inhibitor of IL-6 expression in human PBMC.
Conclusions:
- Recombinant human IL-4 is a potent downregulatory modulator of IL-6 expression in human PBMC.
- IL-4 can suppress IL-6 production irrespective of the activation stimulus.
- These findings highlight IL-4's role in controlling inflammatory responses mediated by IL-6.